Changes in tyrosine hydroxylase gene expression in mesencephalic catecholaminergic neurons of immature and adult male rats perinatally exposed to cannabinoids.
We have previously reported that the perinatal exposure of pregnant rats to cannabinoids affected the activity of tyrosine hydroxylase (TH) in the striatum of their male offspring at peripubertal ages. In the present work, we examined whether this effect was accompanied by modifications in TH gene expression. The amount of TH-mRNA--measured by Northern blot analysis with a specific TH probe--in the mesencephalon of 15- and 20-day-old male rats perinatally exposed to hashish extracts was higher than that measured in aged-matched controls. No differences appeared at 30 and 40 days after birth, a priori because they correspond to ages after the hashish withdrawal occurring on day 24 after birth. However, a significant decrease in the amount of TH-mRNA was observed in adult animals (70 days of life) perinatally exposed to hashish. The increase in TH-mRNA concentrations observed in hashish-exposed 15-day-old animals corresponded to an increase in the amount of TH protein, measured by Western blot analysis, in the mesencephalon, with no differences in the striatum. However, the amount of TH protein in both tissues was not modified by perinatal hashish treatment in adult animals, where TH-mRNA amounts had been decreased. In summary, perinatal cannabinoid exposure enhances the expression of the TH gene in mesencephalic catecholaminergic neurons during early peripubertal ages, coinciding with hashish treatment. Normality was found after hashish withdrawal and an interesting decrease in the amount of TH-mRNA appeared in adulthood, although with no reflection on the amount of TH protein.
Bonnin
A
A
Instituto Complutense de Drogodependencias, Facultad de Medicina, Universidad Complutense, Madrid, Spain.
de Miguel
R
R
Rodríguez-Manzaneque
J C
JC
Fernández-Ruiz
J J
JJ
Santos
A
A
Ramos
J A
JA
D000818:Animals; D015152:Blotting, Northern; D015153:Blotting, Western; D002186:Cannabinoids / Q000494:pharmacology*; D002395:Catecholamines / Q000502:physiology; D005260:Female; D015870:Gene Expression / Q000187:drug effects*; D007150:Immunohistochemistry; D008297:Male; D008636:Mesencephalon / Q000187:drug effects* / Q000201:enzymology* / Q000254:growth & development; D017072:Neostriatum / Q000201:enzymology / Q000254:growth & development; D009474:Neurons / Q000187:drug effects / Q000201:enzymology*; D011247:Pregnancy; D011297:Prenatal Exposure Delayed Effects; D012333:RNA, Messenger / Q000096:biosynthesis; D051381:Rats; D017208:Rats, Wistar; D014446:Tyrosine 3-Monooxygenase / Q000096:biosynthesis / Q000235:genetics*
D002186:Cannabinoids; D002395:Catecholamines; D012333:RNA, Messenger; D014446:Tyrosine 3-Monooxygenase